Literature DB >> 22665600

Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, India.

Vidya Nand Rabi Das1, Alok Ranjan, Krishna Pandey, Dharmendra Singh, Neena Verma, Sushmita Das, Chandra S Lal, Naresh K Sinha, Rakesh B Verma, Niyamat A Siddiqui, Pradeep Das.   

Abstract

Post-kala-azar dermal leishmaniasis (PKDL) has important public health implications for transmission of visceral leishmaniasis (VL). Clinical and epidemiologic profiles of 102 PKDL patients showed that median age of males and females at the time of diagnosis was significantly different (P = 0.013). A significant association was observed between family history of VL and sex of PKDL patients (χ(2) = 5.72, P < 0.01). Nearly 33% of the patients showed development of PKDL within one year of VL treatment. The observed time (median = 12 months) between appearance of lesions and diagnosis is an important factor in VL transmission. A significant association was observed between type of lesions and duration of appearance after VL treatment (χ(2) = 6.59, P = 0.001). Because PKDL was observed during treatment with all currently used anti-leishmanial drugs, new drug regimens having high cure rates and potential to lower the PKDL incidence need to be investigated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22665600      PMCID: PMC3366539          DOI: 10.4269/ajtmh.2012.11-0467

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Leishmaniasis in India.

Authors:  P C Gupta
Journal:  J Indian Med Assoc       Date:  1968-01-01

Review 2.  Post-kala-azar dermal leishmaniasis.

Authors:  V Ramesh; A Mukherjee
Journal:  Int J Dermatol       Date:  1995-02       Impact factor: 2.736

3.  The leishmaniases. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1984

4.  Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas?

Authors:  M Addy; A Nandy
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

Review 5.  The increase in risk factors for leishmaniasis worldwide.

Authors:  P Desjeux
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.184

6.  Screening sandflies for natural infection with Leishmania donovani, using a non-radioactive probe based on the total DNA of the parasite.

Authors:  D S Dinesh; S K Kar; K Kishore; A Palit; N Verma; A K Gupta; D S Chauhan; D Singh; V D Sharma; V M Katoch
Journal:  Ann Trop Med Parasitol       Date:  2000-07

7.  Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.

Authors:  C P Thakur; Amit Kumar; Gaurab Mitra; Shabnam Thakur; P K Sinha; P Das; S K Bhattacharya; Arun Sinha
Journal:  Indian J Med Res       Date:  2008-07       Impact factor: 2.375

8.  Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes.

Authors:  C P Thakur; K Kumar
Journal:  Ann Trop Med Parasitol       Date:  1992-08

9.  Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis.

Authors:  E E Zijlstra; A M el-Hassan; A Ismael; H W Ghalib
Journal:  Am J Trop Med Hyg       Date:  1994-12       Impact factor: 2.345

Review 10.  Post-kala-azar dermal leishmaniasis.

Authors:  E E Zijlstra; A M Musa; E A G Khalil; I M el-Hassan; A M el-Hassan
Journal:  Lancet Infect Dis       Date:  2003-02       Impact factor: 25.071

View more
  17 in total

1.  Post-kala-Azar dermal leishmaniasis: A diagnostic dilemma in a nonendemic area.

Authors:  Prachi Bhandare; Pankaj Shukla; Mayur Bhobe; Varadraj V Pai
Journal:  Indian Dermatol Online J       Date:  2014-12

2.  PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India.

Authors:  Swagata Ganguly; Pabitra Saha; Moytrey Chatterjee; Surajit Roy; Tamal Kanti Ghosh; Subhasish K Guha; Pratip K Kundu; Dilip K Bera; Nandita Basu; Ardhendu K Maji
Journal:  PLoS Negl Trop Dis       Date:  2015-10-20

Review 3.  Post kala-azar dermal leishmaniasis: an unresolved mystery.

Authors:  Debanjan Mukhopadhyay; Jane E Dalton; Paul M Kaye; Mitali Chatterjee
Journal:  Trends Parasitol       Date:  2014-01-02

4.  The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral Leishmaniasis.

Authors:  Stephen Patterson; Susan Wyllie; Laste Stojanovski; Meghan R Perry; Frederick R C Simeons; Suzanne Norval; Maria Osuna-Cabello; Manu De Rycker; Kevin D Read; Alan H Fairlamb
Journal:  Antimicrob Agents Chemother       Date:  2013-07-15       Impact factor: 5.191

5.  Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.

Authors:  Sakib Burza; Prabhat Kumar Sinha; Raman Mahajan; Marta González Sanz; María Angeles Lima; Gaurab Mitra; Neena Verma; Pradeep Das
Journal:  PLoS Negl Trop Dis       Date:  2014-01-02

6.  Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study.

Authors:  Shyam Sundar; Krishna Pandey; Chandreshwar Prasad Thakur; Tara Kant Jha; Vidya Nand Ravi Das; Neena Verma; Chandra Shekhar Lal; Deepak Verma; Shahnawaz Alam; Pradeep Das
Journal:  PLoS Negl Trop Dis       Date:  2014-09-18

7.  Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study.

Authors:  Sushmita Das; Rakesh Mandal; Vidya Nand Rabidas; Neena Verma; Krishna Pandey; Ashok Kumar Ghosh; Sreekant Kesari; Ashish Kumar; Bidyut Purkait; Chandra Sekhar Lal; Pradeep Das
Journal:  PLoS Negl Trop Dis       Date:  2016-10-24

8.  Utility of Blood as the Clinical Specimen for the Molecular Diagnosis of Post-Kala-Azar Dermal Leishmaniasis.

Authors:  Keerti Kaumudee Dixit; V Ramesh; Shreya Upadhyay; Abhishek Kumar Singh; Om Prakash Singh; Shyam Sundar; Ruchi Singh; Poonam Salotra
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

Review 9.  Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review.

Authors:  Siddhivinayak Hirve; Marleen Boelaert; Greg Matlashewski; Dinesh Mondal; Byron Arana; Axel Kroeger; Piero Olliaro
Journal:  PLoS Negl Trop Dis       Date:  2016-08-04

10.  Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.

Authors:  V Ramesh; Himanshu Kaushal; Ashwani Kumar Mishra; Ruchi Singh; Poonam Salotra
Journal:  BMC Public Health       Date:  2015-10-26       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.